Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Iconovo

1.7

 

SEK

 

-1.16 %

Less than 1K followers

ICO

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus

Iconovo is a medical technology company. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and carbon monoxide, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and is headquartered in Lund.

Read more
Market cap
90.2M SEK
Turnover
176.95K SEK
Revenue
2.93M
EBIT %
-1,402.05 %
P/E
-
Dividend yield-%
-
Financial calendar
14/7
2025

Interim report Q2'25

24/10
2025

Interim report Q3'25

All
Press releases
3rd party
ShowingAll content types
Regulatory press release6/11/2025, 2:45 PM

Iconovos företrädesemission har registrerats – omvandling av BTA till aktier

Iconovo
Regulatory press release6/11/2025, 2:45 PM

Iconovo’s rights issue is registered – conversion of BTA into shares

Iconovo
Press release6/11/2025, 6:30 AM

Iconovos utveckling av intranasal GLP-1 för en enklare behandling av fetma gör betydande framsteg

Iconovo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release6/11/2025, 6:30 AM

Iconovo’s development of intranasal GLP-1 for a more convenient treatment of obesity is making significant progress

Iconovo
Regulatory press release6/9/2025, 12:00 PM

Idag, den 9 juni 2025, hölls årsstämma i Iconovo AB. Nedan följer en sammanfattning av de beslut som fattades.

Iconovo
Regulatory press release6/9/2025, 6:15 AM

Iconovos valberedning föreslår val av Christer Fåhraeus som ny styrelseledamot

Iconovo
Regulatory press release6/9/2025, 6:15 AM

Iconovo's nomination committee proposes the election of Christer Fåhraeus as new board member

Iconovo
Regulatory press release6/3/2025, 2:42 PM

Iconovo announces final outcome in the rights issue

Iconovo
Regulatory press release6/3/2025, 2:42 PM

Iconovo offentliggör slutligt utfall i företrädesemissionen

Iconovo
Regulatory press release6/2/2025, 4:50 PM

Iconovo offentliggör preliminärt utfall i företrädesemission

Iconovo
Regulatory press release6/2/2025, 4:50 PM

Iconovo announces preliminary outcome of rights issue

Iconovo
Regulatory press release5/27/2025, 8:30 AM

Sista dag för handel med teckningsrätter i Iconovo

Iconovo
Regulatory press release5/27/2025, 8:30 AM

Last day of trading in subscription rights in Iconovo

Iconovo
Press release5/22/2025, 6:49 AM

BioStock: Iconovo fokuserar på kommersialisering

Iconovo
Press release5/20/2025, 7:31 AM

BioStock: Iconovo tar in kapital och omorganiserar

Iconovo
Press release5/16/2025, 6:31 AM

BioStock: BioStock Investor Pitch: Iconovo

Iconovo
Regulatory press release5/15/2025, 8:30 AM

Iconovo offentliggör informationsdokument avseende företrädesemission av aktier och bjuder in till investerarpresentation

Iconovo
Regulatory press release5/15/2025, 8:30 AM

Iconovo publishes information document regarding rights issue of shares and invites to investor presentation

Iconovo
Regulatory press release5/12/2025, 11:35 AM

Kommuniké från extra bolagsstämma i Iconovo AB den 12 maj 2025

Iconovo
Regulatory press release5/7/2025, 12:20 PM

Kallelse till årsstämma i Iconovo AB

Iconovo
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team